2C-B Facts
Psychedelic;
Description
2C-B (2,5-dimethoxy-4-bromophenethylamine) — Nexus, Bromo, Venus — is a synthetic psychedelic of the phenethylamine class. It activates serotonin receptors in the brain,[1] producing the visual distortion and sensory intensification characteristic of psychedelics, paired with warmth and sociability.
Subjective effects include color enhancement, geometric visual patterns, tactile intensification, heightened sociability, and sensory amplification.[2][3] The experience occupies a boundary between psychedelic perception and entactogenic warmth — vivid and pleasurable at lower doses, shifting steeply toward full psychedelic territory with small dose increases.
2C-B does not produce physical dependence, and no fatality has been attributed to it in published literature.[4] The dominant risk is its steep dose-response curve — small dose increases can escalate a manageable experience into overwhelming psychedelic intensity.[5]
Dose and durationby route · individual sensitivity varies
Starts in 20 – 45 minLasts 4 – 7 hoursAfter-effects 2 – 6 hours
Body and dependence
- Acute toxicity
- Low
- Chronic toxicity
- Negligible
- Physical dependence
- None
- Psychological dependence
- Negligible
- Withdrawal
- None recorded
- Compulsive redosing
- Negligible
Tolerance
- Builds
- Rapid
- Fully resets after
- 14 days
- Carries over to
- LSD;
psilocybin; mescaline; DMT; 2C-E; 2C-I; DOB
Effectslikely at a common dose
- Perception
- Music enhancement;
Visual drifting; Color alteration; Symmetrical texture repetition; Color enhancement; Touch enhancement; Environmental patterning; Geometry; Visual breathing; +27 possible, including Visual haze / noise, Spatial disorientation, Vestibular distortion - Body
- Stimulation;
Spontaneous body sensations; Pupil dilation; Body high; Body scan awareness; Tactile euphoria; +34 possible, including Nausea, Temperature dysregulation, Excessive sweating - Thinking
- Novelty enhancement;
Aesthetic enhancement; Openness enhancement; +34 possible, including Memory suppression, Cognitive impairment, Decision impairment - Feeling
- Emotional enhancement;
Euphoria; +8 possible, including Emotional lability, Anxiety, Dysphoria - Self
- none likely · 9 possible, including Derealization, Depersonalization
- Time
- none likely · 5 possible, including Temporal disorientation
- Transpersonal
- none likely · 1 possible
- Awareness
- none likely · 4 possible
Who shouldn't take it
Combinations61 recorded
Seek help immediately if
Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:
- Very high body temperature; hot, dry skin
- Seizures
- Chest pain; fast or irregular heartbeat
- Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
- Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
- Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm
What to do
- Stay calm and reassure — remind them they took a drug and the effect will pass
- Move to a calm, quiet, safe space with low light; reduce noise and sensory input
- Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
- Talk them down gently; don't grab or restrain unless they're in danger
- For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
- If overheating, cool the body; be ready to give rescue breaths / CPR
The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Papaseit E, Farre M, Perez-Mana C, Torrens M, Ventura M, Pujadas M, de la Torre R, Gonzalez D (2018) Acute Pharmacological Effects of 2C-B in Humans: An Observational Study — Frontiers in Pharmacology doi:10.3389/fphar.2018.00206
- [2]^Caudevilla-Galligo F, Riba J, Ventura M, Gonzalez D, Farre M, Barbanoj MJ, Bouso JC (2012) 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects — Journal of Psychopharmacology doi:10.1177/0269881111431752
- [3]^Gonzalez D, Torrens M, Farre M (2015) Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions — BioMed Research International doi:10.1155/2015/643878
- [4]^Dean BV, Stellpflug SJ, Burnett A, Engebretsen KM (2013) 2C or Not 2C: Phenethylamine Designer Drug Review — Journal of Medical Toxicology doi:10.1007/s13181-013-0295-x
- [5]